Association of patient factors and health-related quality of life with weight changes during chemotherapy for colorectal cancer: secondary analysis of the SCOT trial
Younger patients, males, and those with higher HRQoL experienced greater weight gain during chemotherapy for colorectal cancer, emphasising the need to monitor and manage body weight to prevent increase in obesity during curative treatment.
Authors
- Sara Faithfull (ORCID: https://orcid.org/0000-0002-7951-0243)
- A. Harkin
- T. S. Varghese
- T. Iveson
- M. P. Saunders
- A. Frampton
- A. Lemanska
- C. Kelly
- M. E. Phillips
Institutions
- King's College London (GB)
- Trinity College Dublin (IE)
- University of Surrey (GB)
- NIHR Imperial Biomedical Research Centre (GB)
- The Christie Hospital (GB)
- Royal Surrey NHS Foundation Trust (GB)
- University of Southampton (GB)
- Imperial College London (GB)
- University of Glasgow (GB)
Publication Details
- Journal
- Supportive Care in Cancer
- Published
- 2026-02-19
- DOI
- https://doi.org/10.1007/s00520-026-10441-3
- Primary Topic
- Cancer Risks and Factors
- Type
- article
- Field-Weighted Citation Impact
- 0.00